Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.79
+0.01 (0.15%)
At close: Jul 30, 2026, 4:00 PM EDT
7.13
+0.34 (4.97%)
After-hours: Jul 30, 2026, 6:23 PM EDT

Kyntra Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.446.4429.6246.8140.73235.31
Revenue Growth
6.35%-78.26%-36.71%-66.74%-40.19%33.46%
Gross Profit
3.035.8814.0642.84120.45222.44
Operating Income
-44.79-45.9-150.42-322.72-301.03-288.53
Net Income
163.62183.45-47.58-284.23-293.65-290.02
Earnings Per Share
40.4645.37-11.89-73.00-78.50-78.50
EPS Growth
------

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
-26.1112.9612.5246.12
Europe
5.646.279.5533.82131.24
Japan
0.8-2.8515.879.762.31
China
-0.098.4384.6355.64
Total
6.4429.6246.8140.73235.31

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
87.2488.9850.48203.45422.01405.19
Total Debt
67.4165.98131.96201.03139.2299.72
Net Cash (Debt)
19.8323-81.472.42282.79305.47
Net Cash Growth
----99.14%-7.42%-52.77%
Net Cash Per Share
4.905.69-20.360.6275.5582.69

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.38-4.77-138-315.02-145.93-82.23
Capital Expenditures
-0.02-0.04-0.27-2.52-3.74-5.19
Free Cash Flow
-21.4-4.81-138.27-317.54-149.67-87.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.70%91.37%47.47%91.53%85.59%94.53%
Operating Margin
-602.14%-712.65%-507.80%-689.53%-213.90%-122.62%
Pretax Margin
-761.70%-905.19%-517.76%-690.60%-209.52%-123.53%
Profit Margin
-760.47%-903.79%-516.86%-690.06%-209.27%-123.38%
FCF Margin
-287.70%-74.72%-466.78%-678.46%-106.35%-37.15%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
0.170.19----
Forward PE
-201.74201.74201.74201.74201.74
PS Ratio
3.695.521.801.8710.725.57